Bashir Sanaullah, Tariq Maryam, Aslam Hafiz Muhammad, Hashmi Abdul Sattar M, Malik Baber, Amin Akhtar, Mumtaz Sidra
Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan.
Department of Neurosurgery, Jinnah Postgraduate Medical Center, Karachi, Pakistan.
J Med Case Rep. 2015 Apr 29;9:96. doi: 10.1186/s13256-015-0561-4.
Dermatofibrosarcoma protuberans is a rare, locally aggressive cutaneous tumor of intermediate to low-grade malignancy. COL1A1-PDGFβ translocation is specific to dermatofibrosarcoma protuberans, where the abnormally fused COL1A1-PDGFβ gene directs formation of an abnormal combined (fusion) protein that researchers believe to ultimately function like the platelet-derived growth factor-beta protein.
In this report, we present a case of a 63-year-old Asian man with dermatofibrosarcoma protuberans of the right orbit with intracranial extension. He had a prior history of recurrent leiomyomas at the identical site. He underwent near-total en bloc resection of the tumor through a wide craniectomy with a 6 cm rim of the frontal scalp, allowing the tumor to be resected en bloc, leaving negative margins. Microscopically, the tumor comprised spindle cells with mild nuclear atypia and a low mitotic index embedded in a spiraling pattern of decussating fascicles consistent with dermatofibrosarcoma protuberans. The lesion was positive for CD34 and BCL2. Following resection, the patient was started on imatinib mesylate therapy (800 mg/day).
We propose that platelet-derived growth factor, which has been implicated in the progression of leiomyomas by augmenting mitogenesis, may have acted in an autocrine manner to cause cell division, which may have led to the development of dermatofibrosarcoma protuberans in our patient. Further research is imperative to find certain molecular associations between the discussed soft tissue tumors. Also important is the effective utilization of platelet-derived growth factor receptor kinase inhibitors to prevent transformation to any platelet-derived growth factor-driven tumor, which in our patient was a dermatofibrosarcoma protuberans.
隆突性皮肤纤维肉瘤是一种罕见的、局部侵袭性的中低级别恶性皮肤肿瘤。COL1A1-PDGFβ易位是隆突性皮肤纤维肉瘤所特有的,在此情况下,异常融合的COL1A1-PDGFβ基因指导形成一种异常的复合(融合)蛋白,研究人员认为该蛋白最终的功能类似于血小板衍生生长因子-β蛋白。
在本报告中,我们呈现了一例63岁亚洲男性患者,其患有累及颅内的右侧眼眶隆突性皮肤纤维肉瘤。他既往在同一部位有平滑肌瘤复发史。他通过广泛颅骨切除术及切除6厘米边缘的额部头皮进行了肿瘤的近全整块切除,使得肿瘤能够整块切除,切缘阴性。显微镜下,肿瘤由具有轻度核异型性和低有丝分裂指数的梭形细胞组成,呈螺旋状交叉束状排列,符合隆突性皮肤纤维肉瘤。病变CD34和BCL2呈阳性。切除术后,患者开始接受甲磺酸伊马替尼治疗(800毫克/天)。
我们提出,通过增强有丝分裂而与平滑肌瘤进展相关的血小板衍生生长因子,可能以自分泌方式作用导致细胞分裂,这可能导致了我们患者发生隆突性皮肤纤维肉瘤。必须进行进一步研究以发现所讨论的软组织肿瘤之间的某些分子关联。同样重要的是有效利用血小板衍生生长因子受体激酶抑制剂来预防向任何由血小板衍生生长因子驱动的肿瘤转化,在我们的患者中该肿瘤为隆突性皮肤纤维肉瘤。